A virus is made up of a core of genetic material, either DNA or RNA, surrounded by a protective coat called a capsid which is made up of protein.
Viruses are tiny infectious agents that invade host cells and cause disease. Although they are harmful, viruses also have interesting technological potential.
First seen as poisons, then as life-forms, then biological chemicals, viruses today are thought of as being in a gray area between living and nonliving: they cannot replicate on their own but can do so in truly living cells and can also affect the behavior of their hosts profoundly.
Today, HIV can be kept under control, but for most people, there is no cure because the virus can become dormant so, HIV medicines have no effect.
People with HIV can take antiviral medicines that stop the virus from reproducing, giving them nearly normal lifespans. But HIV inserts copies of its genetic material into human immune cells, which then become dormant. As a result, people have to take the antivirals for the rest of their lives because, if they stop, viruses inside the cells wake up and start infecting more and more immune cells.
An existing cancer drug has been found to also wake up dormant HIV, and it could eventually work with an HIV medicine in a "kick and kill" strategy
Now, a drug already used to treat cancer has been found to make HIV reactivate. To be turned into a cure, it would have to be combined with a second kind of medicine that kills the immune cells churning out viruses. No such medicine is yet proven to work, although some experimental versions are in development.
The idea that dormant viruses could be reactivated before being destroyed is sometimes known as a “kick and kill” strategy. In the latest work, Sharon Lewin at the University of Melbourne, Australia, and her colleagues studied people with HIV who also had cancer and were being treated with a relatively new medicine.
This is an antibody that blocks a protein on immune cells called PD-1, which normally acts as a brake on immune cell activity. Taking away the brake helps the immune system attack cells.
It now seems that removing the brake also makes HIV inside dormant immune cells wake up.
But the approach needs further work, as strategies to kill immune cells with actively replicating HIV, such as vaccines and antibodies, are still in development. “It’s an additional tool that we can use to perturb the HIV reservoir, and we would need that in combination with other interventions,” says Lewin.
Other researchers have found that combining another cancer medicine with an experimental HIV vaccine let some people – although only a minority – stop taking their antiviral drugs for several months without HIV levels rebounding.
Over the past two years, we have witnessed evolution in action, with new variants of the coronavirus becoming increasingly contagious. But where will it end? Is there a ceiling that viruses reach where they can’t become any more contagious?
Despite migraine being among the most common neurological conditions, affecting around a billion people worldwide, we know incredibly little about what causes them, how to avoid them and how best to treat them.
You must be logged in to post a comment.